Overview

Drug Use Investigation for PAXIL Tablet

Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
This post-marketing surveillance study is designed to detect adverse events (particularly clinically significant adverse drug reactions) occurring in clinical settings and to examine factors likely to affect the safety and efficacy of paroxetine.
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Paroxetine